Back to resultsOlanzapine Versus An Active Comparator in the Treatment of Schizophrenia
Primary Purpose
Schizophrenia
Status
Completed
Phase
Phase 4
Locations
International
Study Type
Interventional
Intervention
Olanzapine
Sponsored by
About this trial
This is an interventional treatment trial for Schizophrenia
Eligibility Criteria
Inclusion: You must be between the ages of 18 and 75. If you have reached your 76th birthday, you will not be able to participate You must have been diagnosed with schizophrenia You must be able to visit the doctor's office as scheduled for the next 7 months Exclusion: You have a serious medical illness, such as heart, liver, or kidney disease (Note: If you are uncertain about a particular condition, discuss it with your doctor.) You are either pregnant or breastfeeding
Sites / Locations
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00036088
Brief Title
Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
Study Type
Interventional
2. Study Status
Record Verification Date
July 2006
Overall Recruitment Status
Completed
Study Start Date
August 2001 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
July 2002 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Eli Lilly and Company
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to determine how Olanzapine compares to an active comparator in the treatment of schizophrenia
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
530 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Olanzapine
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion:
You must be between the ages of 18 and 75. If you have reached your 76th birthday, you will not be able to participate
You must have been diagnosed with schizophrenia
You must be able to visit the doctor's office as scheduled for the next 7 months
Exclusion:
You have a serious medical illness, such as heart, liver, or kidney disease (Note: If you are uncertain about a particular condition, discuss it with your doctor.)
You are either pregnant or breastfeeding
Facility Information:
City
El Centro
State/Province
California
Country
United States
City
Glendale
State/Province
California
Country
United States
City
Sherman Oaks
State/Province
California
Country
United States
City
Middleton
State/Province
Connecticut
Country
United States
City
Norwich
State/Province
Connecticut
Country
United States
City
Melbourne
State/Province
Florida
Country
United States
City
Miami
State/Province
Florida
Country
United States
City
Atlanta
State/Province
Georgia
Country
United States
City
Chicago
State/Province
Illinois
Country
United States
City
Hoffman Estates
State/Province
Illinois
Country
United States
City
Lafayette
State/Province
Indiana
Country
United States
City
Rockville
State/Province
Maryland
Country
United States
City
Newton
State/Province
Massachusetts
Country
United States
City
St Charles
State/Province
Missouri
Country
United States
City
New York
State/Province
New York
Country
United States
City
Olean
State/Province
New York
Country
United States
City
Staten Island
State/Province
New York
Country
United States
City
Cincinnati
State/Province
Ohio
Country
United States
City
Portland
State/Province
Oregon
Country
United States
City
Philadelphia
State/Province
Pennsylvania
Country
United States
City
Austin
State/Province
Texas
Country
United States
City
El Paso
State/Province
Texas
Country
United States
City
Houston
State/Province
Texas
Country
United States
City
Terrell
State/Province
Texas
Country
United States
City
Richmond
State/Province
Virginia
Country
United States
City
La Plata
State/Province
Buenos Aires
Country
Argentina
City
Godoy Cruz
State/Province
Mendoza
Country
Argentina
City
Buenos Aires
Country
Argentina
City
Ciudad De Buenos Air
Country
Argentina
City
Graz
Country
Austria
City
Innsbruck
Country
Austria
City
Linz
Country
Austria
City
Wein
Country
Austria
City
Wels
Country
Austria
City
Salvador
State/Province
Bahia
Country
Brazil
City
Aparecida De Goiania
State/Province
Goias
Country
Brazil
City
Pelotas
State/Province
RS
Country
Brazil
City
Rio De Janeiro
Country
Brazil
City
Sau Paulo
Country
Brazil
City
Essen
Country
Germany
City
Hamburg
Country
Germany
City
Tubingen
Country
Germany
City
Dublin
Country
Ireland
City
Mexico City
Country
Mexico
City
Lima
Country
Peru
City
Cidra
Country
Puerto Rico
City
Ponce
Country
Puerto Rico
City
Rio Piedras
Country
Puerto Rico
City
San Juan
Country
Puerto Rico
City
Sama De Langreo
State/Province
Asturias
Country
Spain
City
San Boi De Llobregat
State/Province
Barcelona
Country
Spain
City
Elizondo
State/Province
Navarra
Country
Spain
City
Pamplona
State/Province
Navarra
Country
Spain
City
Barcelona
Country
Spain
City
Camberwell
State/Province
London
Country
United Kingdom
City
Kings Lynn
State/Province
Norfolk
Country
United Kingdom
City
Paisley
State/Province
Scotland
Country
United Kingdom
City
Guildford
State/Province
Surrey
Country
United Kingdom
City
London
Country
United Kingdom
City
Caracas
Country
Venezuela
12. IPD Sharing Statement
Citations:
PubMed Identifier
21586165
Citation
Liu-Seifert H, Ascher-Svanum H, Osuntokun O, Jen KY, Gomez JC. Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics. BMC Psychiatry. 2011 May 17;11:87. doi: 10.1186/1471-244X-11-87.
Results Reference
derived
Learn more about this trial
Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
We'll reach out to this number within 24 hrs